Related Experiment Video
Updated: Jun 5, 2025
10:34
Preparation of Quality Inositol Pyrophosphates
Published on: September 3, 2011
13.1K
Preventing epileptogenesis by interaction between inositol isomers and proteins
Lia Tsverava1,2, Luka Kharkhelauri1, Vincenzo Lagani1,3
1Institute of Chemical Biology, Ilia State University, Tbilisi, Georgia.
Epilepsia Open
|December 5, 2024
Summary
Three inositol isomers, myo-inositol, scyllo-inositol, and D-chiro-inositol, effectively reduce seizures and cognitive deficits in an epilepsy model. These compounds show promise for preventing epileptogenesis and its associated comorbidities.
Area of Science:
- Biochemistry and Neuroscience
- Pharmacology and Drug Discovery
Background:
- Inositols, particularly myo-inositol (MI), are crucial in cellular functions like osmoregulation and signal transduction.
- While MI shows antiepileptogenic potential, its mechanisms and the effects of other isomers like scyllo-inositol (SCI) and D-chiro-inositol (DCHI) remain largely unexplored.
- Understanding inositol-protein interactions is key to elucidating their biological roles and therapeutic potential.
Purpose of the Study:
- To identify proteins that interact with different inositol isomers.
- To evaluate the antiepileptogenic effects of MI, SCI, and DCHI in a rat model of kainic acid-induced epilepsy.
- To assess the impact of inositol treatment on cognitive deficits associated with epilepsy.
Main Methods:
- Proteins interacting with inositols were identified using cellular thermal shift assay.
- Epilepsy was induced in rats using kainic acid (KA), followed by 28-day treatment with MI, SCI, DCHI, or saline.
- Seizure activity, duration, and cognitive function (Morris water maze) were monitored, with protein level changes analyzed via Western immunoblotting.
Main Results:
- Several common and isomer-specific inositol-interacting proteins were identified.
- SCI and DCHI, along with MI, significantly reduced seizure frequency and duration in the KA-induced epilepsy model, with effects lasting up to 4 weeks post-treatment.
- All three inositol isomers ameliorated spatial learning and memory impairments, and alterations in alpha synuclein and 14-3-3 theta were observed in brain regions post-seizure.
Conclusions:
- Myo-inositol, SCI, and DCHI interact with various proteins involved in diverse biological pathways.
- All tested inositol isomers demonstrated long-term efficacy against kainic acid-induced seizures and associated comorbidities.
- Inositols represent a promising therapeutic avenue for translational research in epilepsy and related neurological conditions.
More Related Videos
Related Concept Videos
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
328
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
328
01:14Antiepileptic Drugs: Glutamate Antagonists
281
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
281
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
248
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
248
01:20Antiepileptic Drugs: Potassium Channel Activators
144
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
144
01:24Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
01:08Antiepileptic Drugs: Sodium Channel Blockers
415
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
415